Common questions about Вентолин Эвохалер (FAQ)
Q: Does this inhaler contain hormones?
A: The active ingredient in this medication is salbutamol (or albuterol), which is classified as a short-acting beta-agonist (SABA). According to the official product information, it is not a corticosteroid or hormone medicine.
Q: How long does the effect of one dose usually last?
A: Official regulatory documents indicate that the bronchodilation effect from a single dose of salbutamol typically lasts for approximately four to six hours in most individuals. This range of duration is typical for a rescue medication.
Q: Are there long-term side effects from regular use of Ventolin Evohaler?
A: Regulatory warnings state that tolerance may develop with the frequent or regular use of this type of medication. This means that the bronchodilator effect may decrease over time. If the frequency of use increases, it is a signal of deteriorating control that requires medical guidance.
Q: Is the side effect of dry mouth common?
A: Dry mouth is one of the commonly observed adverse effects reported during the use of salbutamol. Official regulatory sources list this as a known side effect.
Q: Is there evidence that Ventolin becomes less effective over time?
A: Yes, official warnings note the potential for tolerance to develop with repeated and frequent use of beta-agonists. This tolerance can result in the bronchodilating effect becoming less pronounced over time.
Q: What are the restrictions for use in elderly patients?
A: Regulatory information states that the dosage for patients aged 12 years and over, including elderly patients, corresponds to the standard adult dose. There are no specific age-related restrictions detailed in the official documents beyond general precautions for patients with specific underlying health conditions.
Q: Can Ventolin Evohaler cause insomnia or trouble sleeping?
A: Yes, official lists of side effects confirm that both sleeplessness (insomnia) and other disturbances of sleep have been reported in association with the use of salbutamol.
Q: Why do I get a metallic taste in my mouth after using it?
A: A change in taste, also known as taste alteration or an unpleasant taste, is listed in official documents as a commonly reported side effect. This is a registered adverse effect associated with the use of the inhalation aerosol.
Q: Does the use of a spacer change the effect of the medicine?
A: Official administration guidance notes that spacers (or special valve holding chambers) may be used with this medication. Using a spacer can help facilitate administration for patients who struggle to coordinate their breathing with the inhaler actuation, which may help with the delivery of the medication.
Q: Why is rinsing the mouth after use sometimes recommended?
A: While rinsing is not typically required for salbutamol alone, this practice is often noted in instructions when using inhalers that contain corticosteroids (a type of hormone medicine). Rinsing is done to reduce the risk of oral thrush, which is a known issue with inhaled steroids.
Q: How quickly does Ventolin Evohaler start working after inhalation?
A: The drug has a fast onset of action, which is typical for a rescue medication. Official pharmacodynamic data indicates that the bronchodilator effect typically begins within five minutes of inhalation.
Q: Can Ventolin Evohaler be used while taking blood pressure medicine?
A: Co-administration with beta-blockers, a common class of blood pressure medicine, is generally not recommended according to regulatory labels. These agents may inhibit the bronchodilator effect of salbutamol and potentially cause severe bronchospasm.
Q: Are there known interactions between Ventolin Evohaler and over-the-counter cold medicines?
A: Official guidance advises caution when administering other adrenergic drugs (sympathomimetics) from any source, including some over-the-counter cold medicines. This is due to the potential risk of unwanted cardiovascular effects when combining these types of medications.
Q: What is the difference between Ventolin Evohaler and other salbutamol inhalers?
A: This specific product utilizes a non-CFC propellant, HFA 134a, in its composition. Regulatory information notes that patients switching to an HFA-propelled device may experience a different taste compared to older or other inhalers.
Q: What does the research say about the safety of its long-term use?
A: Regulatory warnings focus on the clinical signs of excessive use. Official documents caution that increasing reliance on the medication (using it more frequently) indicates deteriorating asthma control, which requires re-evaluation of the treatment regimen.
Q: Have there been any recent changes to the formulation of Ventolin Evohaler?
A: The current widely available formulation of Ventolin Evohaler uses the propellant HFA 134a. While regulatory studies have been conducted on a next-generation propellant (HFA-152a), the provided official information does not confirm a recent market change to that newer formulation.
Q: Does Ventolin Evohaler affect blood sugar levels?
A: Yes, official regulatory warnings state that salbutamol may cause changes in laboratory tests, including an increase in blood glucose concentrations. This effect leads to the recommendation for cautious use in patients with conditions such as diabetes mellitus.
Q: Why do I sometimes cough immediately after using it?
A: Official reports of adverse effects list both cough and throat irritation as common side effects associated with the use of the inhalation aerosol. This is a known occurrence that can happen immediately following administration.
